Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers
Aldo Clerico, Martina Zaninotto, Claudio Passino, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2020) Vol. 59, Iss. 1, pp. 79-90
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: analytical considerations and clinical relevance
Aldo Clerico, Martina Zaninotto, Alberto Aimo, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 7, pp. 1209-1229
Open Access | Times Cited: 27
Advances in heart failure monitoring: Biosensors targeting molecular markers in peripheral bio-fluids
Tao Dong, Wangang Zhu, Zhaochu Yang, et al.
Biosensors and Bioelectronics (2024) Vol. 255, pp. 116090-116090
Closed Access | Times Cited: 10
Advancements and challenges in high-sensitivity cardiac troponin assays: diagnostic, pathophysiological, and clinical perspectives
Aldo Clerico, Martina Zaninotto, Alberto Aimo, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2025)
Open Access | Times Cited: 1
Clinical relevance of biological variation of cardiac troponins
Aldo Clerico, Andrea Padoan, Martina Zaninotto, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2020) Vol. 59, Iss. 4, pp. 641-652
Open Access | Times Cited: 49
High-sensitivity cardiac troponins in pediatric population
Aldo Clerico, Alberto Aimo, Massimiliano Cantinotti
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 60, Iss. 1, pp. 18-32
Open Access | Times Cited: 36
Role of Cardiac Biomarkers in Cancer Patients
Gennaro Carmine Semeraro, Carlo M. Cipolla, Daniela Cardinale
Cancers (2021) Vol. 13, Iss. 21, pp. 5426-5426
Open Access | Times Cited: 33
High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis
Alberto Aimo, Georgios Georgiopoulos, Giorgia Panichella, et al.
European Journal of Internal Medicine (2022) Vol. 98, pp. 61-68
Open Access | Times Cited: 24
Inflammageing and Cardiovascular System: Focus on Cardiokines and Cardiac-Specific Biomarkers
Marco Alfonso Perrone, Alberto Aimo, Sergio Bernardini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 844-844
Open Access | Times Cited: 15
Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology
Brenda Moura, Alberto Aimo, Abdallah Al‐Mohammad, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 10, pp. 1577-1596
Open Access | Times Cited: 32
Hypoalbuminaemia and heart failure: A practical review of current evidence
Marta Biancucci, Riccardo Barbiero, Benedetta Pennella, et al.
European Journal of Heart Failure (2024)
Open Access | Times Cited: 4
Analytical characteristics and performance of a new hs-cTnI method: a multicenter-study
Tommaso Fasano, Antonio Fortunato, Greta Giacomini, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2025)
Closed Access
Association Between Advanced TNM Stages and Increased Risk of Cardiac Dysfunction in Patients with LVEF < 50%
Sergiu Ioan Murg, Loredana Matiș, Andrada Florina Moldovan, et al.
Medicina (2025) Vol. 61, Iss. 2, pp. 301-301
Open Access
Recent Evidence on Biomarkers for Predicting Cardiovascular Events: A Comprehensive Review
Omar Elsaka
Journal of Indian College of Cardiology (2025) Vol. 15, Iss. 1, pp. 1-12
Open Access
Performance Evaluation of the New High-Sensitivity Cardiac Troponin I Immunoassay on CL-2600i Mindray Analyzer
Flaminia Tomassetti, Denise Fiorelli, E. Cappa, et al.
Diagnostics (2025) Vol. 15, Iss. 8, pp. 1031-1031
Open Access
Associations of Cardiac Biomarkers With Peripheral Artery Disease and Peripheral Neuropathy in US Adults Without Prevalent Cardiovascular Disease
Caitlin W. Hicks, Dan Wang, Katherine M. McDermott, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 8, pp. 1583-1591
Open Access | Times Cited: 10
Relationship between body mass index, cardiovascular biomarkers and incident heart failure
Navin Suthahar, Laura M G Meems, Dion Groothof, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 3, pp. 396-402
Open Access | Times Cited: 22
High-sensitivity methods for cardiac troponins: The mission is not over yet
Aldo Clerico, Martina Zaninotto, Claudio Passino, et al.
Advances in clinical chemistry (2020), pp. 215-252
Closed Access | Times Cited: 23
Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy
Aldo Clerico, Martina Zaninotto, Alberto Aimo, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021)
Open Access | Times Cited: 18
Cardiac Biomarkers for the Detection and Management of Cancer Therapy-Related Cardiovascular Toxicity
Xinxin Zhang, Yuxi Sun, Yanli Zhang, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 11, pp. 372-372
Open Access | Times Cited: 13
High sensitivity troponins: A potential biomarkers of cardiovascular risk for primary prevention
Luís Leite, Pedro Matos, Antonio León‐Justel, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 13
High-sensitivity cardiac troponin I for cardiovascular risk stratification in apparently healthy individuals
Dimitrios Farmakis, Dimitrios Richter, Genovefa Chronopoulou, et al.
Hellenic Journal of Cardiology (2023) Vol. 75, pp. 74-81
Open Access | Times Cited: 7
The Value of Troponin as a Biomarker of Chemotherapy-Induced Cardiotoxicity
Victoriţa Şorodoc, Oana Sîrbu, Cătălina Lionte, et al.
Life (2022) Vol. 12, Iss. 8, pp. 1183-1183
Open Access | Times Cited: 12
The Effects of Physical Inactivity and Exercise at Home in Young Patients with Congenital Heart Disease during the COVID-19 Pandemic
Federica Gentili, Giulia Cafiero, Marco Alfonso Perrone, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 19, pp. 10065-10065
Open Access | Times Cited: 15
Evaluation of the cardiovascular risk in patients undergoing major non-cardiac surgery: role of cardiac-specific biomarkers
Aldo Clerico, Martina Zaninotto, Alberto Aimo, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2022) Vol. 60, Iss. 10, pp. 1525-1542
Open Access | Times Cited: 10
Optimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review
Dipti Tiwari, Tar Choon Aw
Diagnostics (2023) Vol. 14, Iss. 1, pp. 87-87
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top